Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) — Cash flow
Operating, investing, and financing cash flow for Dr. Sulaiman Al Habib Medical Services Group Company — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 2,401↓0.5% | 2,413↑17.9% | 2,046↑13.9% | 1,797↑19.7% | 1,501 | |
| Depreciation & Amortization | 672↑59.6% | 421↑34.6% | 313↑1.1% | 309↓1.8% | 315 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -362↓4.2% | -347↓181.7% | 425↓18.9% | 523↑246.0% | 151 | |
| Accounts Receivable | -653↑5.2% | -688↓240.0% | -202↓402.4% | -40↑79.9% | -201 | |
| Inventory | -181↑42.6% | -314↓440.4% | -58↑30.3% | -84↓209.5% | -27 | |
| Accounts Payable | 175↓68.7% | 559↑71.6% | 326↑108.8% | 156↓11.7% | 177 | |
| Other Working Capital | 296↑208.6% | 96↓73.3% | 359↓26.9% | 491↑143.2% | 202 | |
| Other Non-Cash Items | 373↓22.9% | 484↑7.0% | 452↑110.9% | 214↓0.5% | 215 | |
| Net Cash from Operating Activities | 3,085↑3.8% | 2,970↓8.4% | 3,244↑14.1% | 2,844↑30.3% | 2,183 | |
| Operating Cash Flow | 3,085↑3.8% | 2,970↓7.0% | 3,193↑12.3% | 2,844↑30.3% | 2,183 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -2,983↑22.1% | -3,829↓9.5% | -3,497↓131.1% | -1,513↓20.7% | -1,254 | |
| Capital Expenditure | -2,983↑22.1% | -3,829↓9.5% | -3,497↓131.1% | -1,513↓20.7% | -1,254 | |
| Acquisitions | -0.00↓100.0% | 102↑4091.7% | -3↑98.0% | -126 | 0.00 | |
| Purchases of Investments | -3 | 0.00 | 0.00↑100.0% | -300 | 0.00 | |
| Sales & Maturities of Investments | 0.00↓100.0% | 41 | 0.00↓100.0% | 30 | 0.00 | |
| Other Investing Activities | 0.00↑100.0% | -90↓798.7% | 13↑142.7% | -30↓600.0% | 6 | |
| Net Cash from Investing Activities | -2,987↑20.9% | -3,775↓8.3% | -3,487↓79.8% | -1,939↓55.5% | -1,248 | |
| Financing Activities | ||||||
| Net Debt Issuance | 1,067↓62.5% | 2,846↑67.4% | 1,701↑293.3% | 432↑9.2% | 396 | |
| Long-Term Net Debt Issuance | 1,067↓62.5% | 2,846↑67.4% | 1,701↑293.3% | 432↑9.2% | 396 | |
| Short-Term Net Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -1,663↓1.3% | -1,642↓14.4% | -1,435↓26.2% | -1,138↓20.4% | -945 | |
| Common Dividends Paid | -1,663↓1.3% | -1,642↓14.4% | -1,435↓26.2% | -1,138↓20.4% | -945 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -112↑13.5% | -130↓51.2% | -86↑10.7% | -96↓17.4% | -82 | |
| Net Cash from Financing Activities | -707↓165.8% | 1,075↑497.9% | 180↑122.5% | -801↓27.0% | -631 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | -609↓325.3% | 270↑313.5% | -127↓222.7% | 103↓66.1% | 305 | |
| Cash at Beginning of Period | 2,891↑10.3% | 2,620↓4.6% | 2,747↑3.9% | 2,644↑13.0% | 2,339 | |
| Cash at End of Period | 2,282↓21.1% | 2,891↑10.3% | 2,620↓4.6% | 2,747↑3.9% | 2,644 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | 101↑111.8% | -858↓182.4% | -304↓122.8% | 1,330↑43.2% | 929 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.